Clinical trial

Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood

NCT00116311

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention allergen inhalation Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention withdrawal of medication Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention sputum induction Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2005-07-01

PhaseN/A

Conditions

Asthmaverified · MONDO: asthma

Healthyunresolved

Interventions

allergen inhalationBEHAVIORAL

withdrawal of medicationBEHAVIORAL

sputum inductionPROCEDURE

Sponsors & collaborators

Groningen Research Institute for Asthma and COPDlead sponsor

Mapped research locations

GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00116311 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.